A

t a forum on Cape Cod in Massachusetts earlier this month, Harvard scientist David Sinclair had the rapt attention of biotech executives and investors as he described treating 20-month-old mice with a molecule to restore their youthfulness. Before long, the geriatric rodents were outracing 2-month-old mice.

Yes, Sinclair told his audience, “We can turn an old mouse into a healthy young mouse.”

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy